ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Genetically Engineered Hematopoietic Stem Cells Deliver TGF-β Inhibitor to Enhance Bone Metastases Immunotherapy.

Beilei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.